Profil
Timothy J.
Fischer served as President & CEO of HemoSonics LLC.
Prior to that, he was Vice President of Development at Becton, Dickinson & Co. and Vice President of Product Development at TriPath Oncology, Inc. Fischer also served as Chief Operating Officer at LipoScience, Inc. Fischer received his undergraduate degree from Indiana University.
Anciens postes connus de Timothy J. Fischer
| Sociétés | Poste | Fin |
|---|---|---|
| LIPOSCIENCE INC | Directeur des opérations | 01/05/2014 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/09/2010 |
TriPath Oncology, Inc.
TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer | Corporate Officer/Principal | 01/12/2006 |
HemoSonics LLC
HemoSonics LLC Medical/Nursing ServicesHealth Services Operates as a diagnostic center | Directeur Général | - |
Formation de Timothy J. Fischer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Becton, Dickinson & Co.
Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
LipoScience, Inc.
LipoScience, Inc. Medical SpecialtiesHealth Technology Operates as an in vitro diagnostic company for cardiovascular and metabolic diseases using technology platform based on nuclear magnetic resonance | Health Technology |
HemoSonics LLC
HemoSonics LLC Medical/Nursing ServicesHealth Services Operates as a diagnostic center | Health Services |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TriPath Oncology, Inc.
TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer | Commercial Services |
















